Endostar Aggressive Treatment of Peripheral T-cell Lymphoma (PTCL) Phase II Clinical Study

60 participants · First posted Aug 11, 2015

Safety and Efficacy of Epcoritamab With Gemcitabine, Dexamethasone, and Cisplatin (GDP) Salvage Chemotherapy in Relapsed Refractory Large B-cell Lymphoma

35 participants · First posted May 10, 2023

Comparison Study of EAP and Disease-Specific Chemotherapy Regimens in Hematopoietic Stem Cell Mobilization for Lymphoma

99 participants · First posted Jul 25, 2024

GDP-L-fucose

C₁₆H₂₅N₅O₁₅P₂

GDP-alpha-D-mannuronic acid

C₁₆H₂₃N₅O₁₇P₂

SDZ-280636

GCP Laboratories, Inc.

United States

GMP Endotherapeutics Inc

EDP Biotech Corporation

United States

Venus Remedies Receives WHO GDP Certification for Advanced Digital Logistics Operations

Mexico City Unveils US$125 Million Biotech Investment to Build Domestic Biopharmaceutical Manufacturing Capacity

New Zealand's Pharmac Proposes Funding for Two Chronic Lymphocytic Leukemia Combination Therapies